年別の研究成果
年別の研究成果
検索結果
-
2018
Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non–small cell lung cancer
Iwama, E., Nakanishi, Y. & Okamoto, I., 3月 4 2018, In: Expert Review of Anticancer Therapy. 18, 3, p. 267-276 10 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
15 被引用数 (Scopus) -
2015
Clinical benefits associated with first line treatment using afatinib
Iwama, E. & Okamoto, I., 10月 20 2015, In: Japanese Journal of Lung Cancer. 55, 6, p. 866-870 5 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access -
2014
[Personalized medicine in non-small-cell carcinoma].
Iwama, E., Takayama, K., Baba, E. & Nakanishi, Y., 3月 2014, In: Fukuoka igaku zasshi = Hukuoka acta medica. 105, 3, p. 57-66 10 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
1 被引用数 (Scopus) -
Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
Iwama, E., Okamoto, I., Harada, T., Takayama, K. & Nakanishi, Y., 3月 5 2014, In: OncoTargets and Therapy. 7, p. 375-385 11 p.研究成果: ジャーナルへの寄稿 › 総説 › 査読
Open Access41 被引用数 (Scopus)